Hutchmed (China) Limited (HCM) ORD USD0.10
18.50p
(8.60%)
- Add to watchlist
- Create an alert
- This stock can be held in a
18.50p
(8.60%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
18.50p
(8.60%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
228.00p
238.00p
336.00p
£2.02 bn
215.00p
227.87p
187.50p
72.25
12.50p (5.49%) Previous:
12.50p
149,950
n/a
1,500
Performance
| 1 week 1W | 5.18% | 1 year 1Y | 13.2% |
|---|---|---|---|
| 1 month 1M | 14% | 2 years 2Y | 1.58% |
| 3 months 3M | 4.24% | 3 years 3Y | 5.66% |
| 6 months 6M | 9.85% | 5 years 5Y | 53.11% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2024 | 31/12/2023 |
|---|---|---|
| Revenue ($m) | 630.20 | 838.00 |
| Profit before tax ($m) | (1.11) | 58.31 |
| Adjusted EPS (¢): | 4.00 | 12.00 |
| P/E ratio | 79.40 | 31.90 |
| PEG | n/a | n/a |
| EPS growth (%) | (67.00) | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Hutchmed to present new and updated clinical data
5 September 2025 09:45
-
Hutchmed enrols last patient in phase 3 lung cancer trial
20 August 2025 09:16
-
Hutchmed to get milestone payment after China drug approval
30 June 2025 12:29
-
HUTCHMED Highlights Data to be Presented at CSCO
5 September 2025 07:00
-
Directorate Change
26 August 2025 07:00
-
HUTCHMED Completes Enrollment of Phase III Trial
20 August 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.